We asked experts what they make of the J&J vaccine pause
Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
Our reporter tried to find out how much it'd cost to get an MRI - and it turned into a real headache;
Microsoft's $16 billion bid for Nuance gets it in on the ground floor of healthcare.
If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...
Doctors say fears of blood clots from J&J's shot are overdone and could delay the push to end the pandemic
Coronavirus vaccines are facing their biggest safety scare to date.
A small number of people immunized with Johnson & Johnson's or AstraZeneca's shot developed serious blood clots.
A new rule was supposed to force hospitals to reveal their secret prices. But after I spent hours shopping around for an MRI, I learned that not much has changed.
Starting January 1, hospitals were supposed to publish prices they negotiate with insurers.
To see whether the process had gotten easier, reporter Shelby Livingston tried finding prices for an MRI at nearby hospitals.
She was unable to easily compare MRI prices, as most hospitals neglected to post negotiated rates.
Find out how far Shelby got here>>
Microsoft is spending $16 billion to beat Google and Amazon to the ground floor of healthcare
Microsoft is buying Nuance Communications to bulk up its healthcare services.
Nuance is best known for conversational AI that helps doctors with notes.
Microsoft stands to work with more than half of US physicians when the deal goes through.
Read on to see how the cloud wars are heating up>>
More stories we're reading:
Researchers are puzzling over what to make of the link between COVID-19 vaccines and blood clots (Stat News)
What to do if you got the Johnson & Johnson vaccine amid blood clot fears (Insider)
Meet the billionaire who built an empire out of electronic medical records (Forbes)
New data shows Moderna's vaccine remains highly protective 6 months after shots (Insider)
- Lydia
Read the original article on Business Insider